Pepgen Stock Net Income
| PEPG Stock | USD 1.33 0.01 0.76% |
Fundamental analysis of PepGen allows traders to better anticipate movements in PepGen's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Net Loss | -62.2 M | -59.1 M | |
| Net Loss | -90 M | -85.5 M | |
| Net Loss | -90 M | -85.5 M | |
| Net Loss | (2.85) | (2.99) | |
| Net Income Per E B T | 0.99 | 1.12 |
PepGen | Net Income | Build AI portfolio with PepGen Stock |
PepGen Company Net Income Analysis
PepGen's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current PepGen Net Income | (89.98 M) |
Most of PepGen's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PepGen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PepGen Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for PepGen is extremely important. It helps to project a fair market value of PepGen Stock properly, considering its historical fundamentals such as Net Income. Since PepGen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PepGen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PepGen's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
PepGen Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, PepGen reported net income of (89.98 Million). This is 126.37% lower than that of the Biotechnology sector and 228.46% lower than that of the Health Care industry. The net income for all United States stocks is 115.76% higher than that of the company.
PepGen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PepGen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PepGen could also be used in its relative valuation, which is a method of valuing PepGen by comparing valuation metrics of similar companies.PepGen is currently under evaluation in net income category among its peers.
PepGen Institutional Holders
Institutional Holdings refers to the ownership stake in PepGen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of PepGen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PepGen's value.| Shares | Geode Capital Management, Llc | 2025-03-31 | 383.9 K | State Street Corp | 2025-03-31 | 320.1 K | Ikarian Capital, Llc | 2025-03-31 | 150 K | Northern Trust Corp | 2025-03-31 | 141 K | Nuveen, Llc | 2025-03-31 | 98.7 K | Aqr Capital Management Llc | 2025-03-31 | 87 K | Susquehanna International Group, Llp | 2025-03-31 | 75.6 K | Sei Investments Co | 2025-03-31 | 70.1 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 64.8 K | Ra Capital Management, Llc | 2025-03-31 | 10.7 M | Point72 Asset Management, L.p. | 2025-03-31 | 2.7 M |
PepGen Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.41 | ||||
| Current Valuation | (36.32 M) | ||||
| Shares Outstanding | 32.72 M | ||||
| Shares Owned By Insiders | 0.26 % | ||||
| Shares Owned By Institutions | 96.07 % | ||||
| Number Of Shares Shorted | 1.36 M | ||||
| Price To Book | 0.47 X | ||||
| EBITDA | (89.09 M) | ||||
| Net Income | (89.98 M) | ||||
| Cash And Equivalents | 218.82 M | ||||
| Cash Per Share | 9.26 X | ||||
| Total Debt | 18.66 M | ||||
| Current Ratio | 11.01 X | ||||
| Book Value Per Share | 2.81 X | ||||
| Cash Flow From Operations | (82.37 M) | ||||
| Short Ratio | 3.84 X | ||||
| Earnings Per Share | (3.14) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 79 | ||||
| Beta | 1.16 | ||||
| Market Capitalization | 43.19 M | ||||
| Total Asset | 150.88 M | ||||
| Retained Earnings | (271.46 M) | ||||
| Working Capital | 107.06 M | ||||
| Net Asset | 150.88 M |
About PepGen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PepGen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PepGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PepGen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out PepGen Piotroski F Score and PepGen Altman Z Score analysis. For more detail on how to invest in PepGen Stock please use our How to Invest in PepGen guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PepGen. If investors know PepGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PepGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PepGen is measured differently than its book value, which is the value of PepGen that is recorded on the company's balance sheet. Investors also form their own opinion of PepGen's value that differs from its market value or its book value, called intrinsic value, which is PepGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PepGen's market value can be influenced by many factors that don't directly affect PepGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PepGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if PepGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PepGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.